(Q33958795)

English

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine (English)

1 reference

Europe PubMed Central

30 July 2017

Annabel E. Barber

2

object named as

Annabel Barber

1 reference

Europe PubMed Central

18 December 2018

Naji N. Abumrad

5

object named as

Naji N Abumrad

1 reference

Europe PubMed Central

30 July 2017

author name string

Patricia Eubanks May

1

1 reference

Europe PubMed Central

30 July 2017

James T D'Olimpio

3

1 reference

Europe PubMed Central

30 July 2017

Ann Hourihane

4

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

30 July 2017

The American Journal of Surgery

1 reference

Europe PubMed Central

30 July 2017

183

1 reference

Europe PubMed Central

30 July 2017

4

1 reference

Europe PubMed Central

30 July 2017

471-479

1 reference

Europe PubMed Central

30 July 2017

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Protein-calorie undernutrition in hospitalized cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Predicting mortality based on body composition analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Physiologic importance of glutamine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

The effects of l-arginine on crypt cell hyperproliferation in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Supplemental dietary arginine accelerates intestinal mucosal regeneration and enhances bacterial clearance following radiation enteritis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Arginine: biochemistry, physiology, and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Nutritional supplementation of the leucine metabolite beta-hydroxy-beta-methylbutyrate (hmb) during resistance training.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

The cancer anorexia-cachexia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Statistical handling of drop‐outs in longitudinal clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

A comparison of air displacement plethysmography with three other techniques to determine body fat in healthy adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Comparison of air-displacement plethysmography with hydrostatic weighing and bioelectrical impedance analysis for the assessment of body composition in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Whole-body protein metabolism in cancer-bearing patients. Effect of total parenteral nutrition and associated serum insulin response

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Evaluation of a new air displacement plethysmograph for measuring human body composition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Clinical characteristics influencing bioelectrical impedance analysis measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Use of bioelectrical impedance analysis measurements in the clinical management of critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Body-composition changes in patients who gain weight while receiving megestrol acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Thalidomide for the treatment of AIDS-associated wasting

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Cisplatin, vinblastine, and hydrazine sulfate in advanced, non-small-cell lung cancer: a randomized placebo-controlled, double-blind phase III study of the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Effect of growth hormone on tumor and host in an animal model

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Stimulatory effects of growth hormone on rat bladder carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Glutamine suppresses PGE2 synthesis and breast cancer growth

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Beta-hydroxy-beta-methylbutyrate ingestion, Part I: effects on strength and fat free mass

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2802%2900823-1

7 January 2021

Identifiers

10.1016/S0002-9610(02)00823-1

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33958795&oldid=1536501168"